Patients of any age who are diagnosed with influenza A (subtypes A/H1pdm or A/H3) or B using rapid influenza diagnostic tests (RIDTs) were eligible for inclusion
Conditions
Interventions
None listed
Sponsors
Shionogi & Co.,ltd Medical affairs department
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients of any age who were diagnosed with influenza A (subtypes A/H1pdm or A/H3) or B using RIDTs
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Daily secondary infection rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of household members with secondary infections Proportion of households with secondary infections Time to return to normal body temperature (no relapse at least 12hrs continuously) Time to return to normal body temperature (no relapse at least 72hrs continuously) Relapse of fever Time to alleviation of symptoms (6symptoms) Exploratory analysis of new symptomatic index Safety | — |
Countries
Japan
Contacts
Public ContactNobuo Hirotsu
Hirotsu Clinic Internal Medicine, Pediatrics
Outcome results
None listed